Dr. Friedberg is a board-certified and fellowship-trained gastroenterologist. He and his patients work as a team to develop a personalized strategy that makes sense not only medically but for his patients’ lifestyles too.

He has written IBD-related book chapters, taught medical school classes, and led studies on novel medications, including a pioneering study on upadacitinib, the first FDA-approved oral treatment for severe Crohn’s disease. His research has been presented at numerous national and international conferences, as well as featured in top news outlets.

Outside the office, Dr. Friedberg enjoys learning about other cultures, especially through travel. He keeps active by running, biking, playing basketball and tennis, and hiking.